SCHEMBL2634425

SCHEMBL2634425

O=C(O)CCCCCCCCCCCCCCCSC1CC(=O)NC1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.37
IDE P14735 2/20 0.37
RIN1 Q13671 2/20 0.37
PPARG P37231 1/20 0.37
NR2E3 Q9Y5X4 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
PTGIR P43119 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 3/20 0.36
TSHR P16473 2/20 0.36
NFKB1 P19838 1/20 0.36
PMP22 Q01453 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
F13A1 P00488 3/20 0.33
DDB1 Q16531 2/20 0.33
CRBN Q96SW2 2/20 0.33
NSD2 O96028 1/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BHMT Q93088 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2634170 1.00 ABL1 (0.37) ABL1IDERIN1PPARGNR2E3
SCHEMBL11886046 0.80 MAP3K14 (0.33) SMN1; SMN2LMNADDB1CRBN
SCHEMBL24756756 0.80 ALDH1A1 (0.42) SMN1; SMN2LMNADDB1CRBNL3MBTL1
SCHEMBL10489330 0.80 ALDH1A1 (0.42) SMN1; SMN2LMNADDB1CRBNL3MBTL1
SCHEMBL18888757 0.78 NPC1 (0.41) SMN1; SMN2LMNADDB1CRBNL3MBTL1
SCHEMBL27111821 0.76 SMN1; SMN2 (0.36) SMN1; SMN2TDP1DDB1CRBNL3MBTL1
SCHEMBL22765599 0.76 LMNA (0.39) LMNADDB1CRBN
Octanedioate SCHEMBL6037701 0.76 TSHR (0.43) ABL1IDERIN1PPARGNR2E3
SCHEMBL9289932 0.75 PTGIR (0.40) PPARGPTGIRLMNATSHRNFKB1
SCHEMBL24885111 0.74 ABL1 (0.47) ABL1IDERIN1PPARGNR2E3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2437786-B1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE YEDA RES & DEV (IL) 2016-05-18 EP disclosed
US-20150093370-A1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-04-02 US disclosed
US-20150093370-A1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-04-02 US disclosed
US-20120134977-A1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2012-05-31 US disclosed
US-20120134977-A1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2012-05-31 US disclosed
EP-2437786-A1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE Yeda Research and Development Co. Ltd. (IL) 2012-04-11 EP disclosed
WO-2010140148-A1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE YEDA RESEARCH AND DEVELOPMENT CO . LTD (IL) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120134977-A1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE ALB, DNPEP, CNDP2 ABL1 113/4885IDE 757/4885RIN1 3111/4885
US-20150093370-A1 PRODRUGS CONTAINING ALBUMIN BINDING PROBE ALB, DNPEP, CNDP2 ABL1 113/4885IDE 757/4885RIN1 3111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.